Effect of anti-tumor necrosis factor alpha therapy on bone health and biomarkers of bone turnover in Indian patients with ankylosing spondylitis
Background: We evaluated the relationship between bone mineral density (BMD) and biomarkers of bone turnover in ankylosing spondylitis (AS) patients treated with anti-tumor necrosis factor alpha (TNF-α) agents. Methods: Fifty-one AS patients were screened, of which 27 were started on anti-TNF therap...
Main Authors: | Shefali Khanna Sharma, Sandeep Mohanan, Surender K Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=1;spage=31;epage=37;aulast=Sharma |
Similar Items
-
Current treatment approaches in patients with ankylosing spondylitis
by: Bilal Elbey
Published: (2015-03-01) -
Interrupted course of antitumor necrosis factor alpha therapy versus combined nonsteroidal anti-inflammatory drug therapy and physiotherapy in patients with ankylosing spondylitis: A comparative study
by: Sherry K Abdelrahman, et al.
Published: (2021-01-01) -
Liver enzyme elevation in patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors: a single-center historical cohort study
by: Su Jin Choi, et al.
Published: (2020-05-01) -
The usefulness of trabecular bone score in patients with ankylosing spondylitis
by: Seoung Wan Nam, et al.
Published: (2021-09-01) -
A case of chronic lymphocytic leukemia still taking etanercept for ankylosing spondylitis
by: ŞERİFE MEHLİKA KUŞKONMAZ, et al.
Published: (2016-01-01)